Description: WooGene B&G Co., Ltd. develops, manufactures, and markets products to animal health and livestock industry in South Korea and internationally. The company's products include veterinary medicines, raw materials, and probiotic. It offers veterinary medicines for poultry, swine, bovine, horse, dog, cat, sheep, deer, and aquaculture markets; and vaccines for swine, poultry, canine, and cow markets. The company was formerly known as WooJin Co., Ltd. and changed its name to WooGene B&G Co., Ltd. in March 2001. WooGene B&G Co., Ltd. was founded in 1977 and is headquartered in Seoul, South Korea.
Home Page: www.woogenebng.com
775, Gyeongin-ro
Seoul,
South Korea
Phone:
82 2 795 2361
Officers
| Name | Title |
|---|---|
| Mr. Jae-Ku Kang | CEO & Pres |
| Kyung-Duk Yang | Sr. Managing Director |
Exchange: KQ
Country: KR
Currency: Korean Won (₩)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 1.3919 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 98 |